Unacylated ghrelin is associated with changes in body composition and body fat distribution during long-term exercise intervention

European Journal of Endocrinology

Volumn 165, Issue 2, 2011, Pages 243-248

  Cederberg, Henna ^a   Rajala, Ulla ^a   Koivisto, Vesa Matti ^a   Jokelainen, Jari ^a,b   Surcel, Heljä Marja ^c   Keinänen Kiukaanniemi, Sirkka ^a,b,d   Laakso, Markku ^e  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Oulu Health Center   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; UNACYLATED GHRELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CONTROLLED STUDY; EXERCISE; HORMONE BLOOD LEVEL; HUMAN; MALE; MILITARY SERVICE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT REDUCTION; ABDOMINAL OBESITY; ACETYLATION; ATHLETIC PERFORMANCE; BLOOD; CLINICAL TRIAL; KINESIOTHERAPY; METABOLISM; METHODOLOGY; OBESITY; PHYSIOLOGY; TIME; SOLDIER;

ACETYLATION; ADULT; ATHLETIC PERFORMANCE; BODY COMPOSITION; BODY FAT DISTRIBUTION; EXERCISE; EXERCISE THERAPY; GHRELIN; HUMANS; MALE; OBESITY, ABDOMINAL; OVERWEIGHT; TIME FACTORS; WAIST CIRCUMFERENCE; WEIGHT LOSS; YOUNG ADULT;

EID: 79960182458     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0334     Document Type: Article

References (30)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660. (doi:10.1038/45230)
2. Ukkola O. Ghrelin and metabolic disorders. Current Protein and Peptide Science 2009 10 2-7. (doi:10.2174/138920309787315220)
3. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC & Wells T. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 2004 145 234-242. (doi:10.1210/en.2003-0899)
4. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, van der Lely AJ & Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism 2004 89 3062-3065. (doi:10.1210/jc.2003- 031964)
5. Gauna C, Meyler FM, Janssen JA, Delhanty PJ, Abribat T, van Koetsveld P, Hofland LJ, Broglio F, Ghigo E & van der Lely AJ. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2004 89 5035-5042. (doi:10.1210/jc.2004-0363)
6. Gauna C, Delhanty PJ, Hofland LJ, Janssen JA, Broglio F, Ross RJ, Ghigo E & van der Lely AJ. Ghrelin stimulates, whereas desoctanoyl ghrelin inhibits, glucose output by primary hepatocytes. Journal of Clinical Endocrinology and Metabolism 2005 90 1055-1060. (doi:10.1210/jc.2004-1069)
7. Neary NM, Druce MR, Small CJ & Bloom SR. Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut 2006 55 135. (Pubitemid 41820653)
8. St-Pierre DH, Karelis AD, Coderre L, Malita F, Fontaine J, Mignault D, Brochu M, Bastard JP, Cianflone K, Doucet E, Imbeault P & Rabasa-Lhoret R. Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2007 92 264-269. (doi:10.1210/jc.2006-1603)
9. Kim HJ, Lee S, Kim TW, Kim HH, Jeon TY, Yoon YS, Oh SW, Kwak H & Lee JG. Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children. Clinical Endocrinology 2008 68 416-422. (doi:10.1111/j.1365-2265.2007.03058.x)
10. Foster-Schubert KE, McTiernan A, Frayo RS, Schwartz RS, Rajan KB, Yasui Y, Tworoger SS & Cummings DE. Human plasma ghrelin levels increase during a one-year exercise program. Journal of Clinical Endocrinology and Metabolism 2005 90 820-825. (doi:10.1210/jc.2004-2081)
11. Leidy HJ, Gardner JK, Frye BR, Snook ML, Schuchert MK, Richard EL & Williams NI. Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. Journal of Clinical Endocrinology and Metabolism 2004 89 2659-2664. (doi:10.1210/jc.2003-031471)
12. Morpurgo PS, Resnik M, Agosti F, Cappiello V, Sartorio A & Spada A. Ghrelin secretion in severely obese subjects before and after a 3-week integrated body mass reduction program. Journal of Endocrinological Investigation 2003 26 723-727. (Pubitemid 37441500)
13. Ravussin E, Tschop M, Morales S, Bouchard C & Heiman ML. Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins. Journal of Clinical Endocrinology and Metabolism 2001 86 4547-4551. (doi:10.1210/jc.86.9.4547)
14. Cederberg H, Mikkola I, Jokelainen J, Laakso M, Härkönen P, Ikäheimo T, Laakso M & Keinänen-Kiukaanniemi S. Exercise during military training improves cardiovascular risk factors in young men. Atherosclerosis 2011 216 489-495. (doi:10.1016/j.atherosclerosis.2011.02.037)
15. Cooper KH. A means of assessing maximal oxygen intake. Correlation between field and treadmill testing. Journal of the American Medical Association 1968 203 201-204. (doi:10.1001/jama.203.3.201)
16. Grant S, Corbett K, Amjad AM, Wilson J & Aitchison T. A comparison of methods of predicting maximum oxygen uptake. British Journal of Sports Medicine 1995 29 147-152. (doi:10. 1136/bjsm.29.3.147)
17. Santtila M, Kyrolainen H, Vasankari T, Tiainen S, Palvalin K, Hakkinen A & Hakkinen K. Physical fitness profiles in young Finnish men during the years 1975-2004. Medicine and Science in Sports and Exercise 2006 38 1990-1994. (doi:10.1249/01.mss.0000232023.28984.78)
18. Saaristo T, Moilanen L, Korpi-Hyovalti E, Vanhala M, Saltevo J, Niskanen L, Jokelainen J, Peltonen M, Oksa H, Tuomilehto J, Uusitupa M & Keinanen-Kiukaanniemi S. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care 2010 33 2146-2151. (doi:10.2337/dc10-0410)
19. Weigle DS, Cummings DE, Newby PD, Breen PA, Frayo RS, Matthys CC, Callahan HS & Purnell JQ. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. Journal of Clinical Endocrinology and Metabolism 2003 88 1577-1586. (doi:10.1210/jc.2002-021262)
20. Romon M, Gomila S, Hincker P, Soudan B & Dallongeville J. Influence of weight loss on plasma ghrelin responses to high-fat and high-carbohydrate test meals in obese women. Journal of Clinical Endocrinology and Metabolism 2006 91 1034-1041. (doi:10.1210/jc.2005-1050)
21. Bennett NR, Boyne MS, Cooper RS, Royal-Thomas TY, Bennett FI, Luke A, Wilks RJ & Forrester TE. Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change. Clinical Endocrinology 2009 70 408-414. (doi:10.1111/j.1365-2265.2008.03344.x)
22. Kelishadi R, Hashemipour M, Mohammadifard N, Alikhassy H & Adeli K. Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes. Clinical Endocrinology 2008 69 721-729. (doi:10.1111/j.1365-2265.2008.03220.x)
23. Zhang W, Chai B, Li JY, Wang H & Mulholland MW. Effect of desacyl ghrelin on adiposity and glucose metabolism. Endocrinology 2008 149 4710-4716. (doi:10.1210/en.2008-0263)
24. Davies JS, Kotokorpi P, Eccles SR, Barnes SK, Tokarczuk PF, Allen SK, Whitworth HS, Guschina IA, Evans BA, Mode A, Zigman JM & Wells T. Ghrelin induces abdominal obesity via GHSR-dependent lipid retention. Molecular Endocrinology 2009 23 914-924. (doi:10.1210/me.2008-0432)
25. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN & Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity 2006 14 336-341. (doi:10.1038/oby.2006.43)
26. Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH & Kahn SE. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003 52 172-179. (doi:10.2337/diabetes.52.1.172)
27. Howard BV, Ruotolo G & Robbins DC. Obesity and dyslipidemia. Endocrinology and Metabolism Clinics of North America 2003 32 855-867. (doi:10.1016/S0889-8529(03)00073-2)
28. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, Meguid MM & Kasuga M. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005 54 18-24. (doi:10.1136/gut.2004.038737)
29. Tähtinen T, Vanhala M, Oikarinen J & Keinänen-Kiukaanniemi S. Changes in insulin resistance-associated cardiovascular risk factors of Finnish men during military service. Annales Medicinae Militaris Fenniae 2000 75 163-170.
30. Kirchner H, Gutierrez JA, Solenberg PJ, Pfluger PT, Czyzyk TA, Willency JA, Schurmann A, Joost HG, Jandacek RJ, Hale JE, Heiman ML & Tschop MH. GOAT links dietary lipids with the endocrine control of energy balance. Nature Medicine 2009 15 741-745. (doi:10.1038/nm.1997)